Triple Negative Breast Neoplasms
... On-line free medical diagnosis assistant. Ranked list of possible diseases from either ... "Triple Negative Breast Neoplasms"Drugs, active principles and "Triple Negative Breast Neoplasms"Medicinal plantsQuestions and ... Triple Negative Breast Neoplasms. breast neoplasms that do not express ESTROGEN RECEPTORS; progesterone RECEPTORS; and do not ...https://lookfordiagnosis.com/mesh_info.php?term=Triple+Negative+Breast+Neoplasms&lang=1
Compound Report Card
Triple Negative Breast Neoplasms. D064726. EFO:0005537. triple-negative breast cancer. 3. ClinicalTrials. ClinicalTrials. ... Breast Neoplasms. D001943. EFO:0003869. breast neoplasm. 3. ClinicalTrials. ClinicalTrials. Burkitt Lymphoma. D002051. EFO: ... Breast Neoplasms. D001943. EFO:0000305. breast carcinoma. 3. ClinicalTrials. Carcinoma. D002277. EFO:0000313. carcinoma. 3. ... Esophageal Neoplasms. D004938. EFO:0002916. esophageal carcinoma. 2. ClinicalTrials. Breast Neoplasms, Male. D018567. EFO: ...https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL53463
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer - Full Text...
Breast Neoplasms. Triple Negative Breast Neoplasms. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. ... Breast Cancer HER-2 Positive Breast Cancer Triple Negative Breast Cancer ER/Progressive Response (PR) + Refractory to Prior ... Experimental: Triple negative breast cancer Closed to enrollment. Drug: ganetespib Ganetespib 150 mg/m2 will be administered ... is effective in the treatment of patients with HER2+ or triple negative breast cancer who have not received prior systemic ...https://clinicaltrials.gov/ct2/show/NCT01677455?recr=Open&cond=%22Triplets%22&rank=14
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 and ABBV-368 With and...
Triple Negative Breast Neoplasms. Squamous Cell Carcinoma of Head and Neck. Neoplasms. Carcinoma. Neoplasms, Glandular and ... Breast Neoplasms. Neoplasms by Site. Breast Diseases. Skin Diseases. Lung Neoplasms. Respiratory Tract Neoplasms. Thoracic ... Arm 1 (triple-negative breast cancer [TNBC]): Participants with confirmed breast adenocarcinoma that is estrogen receptor/ ... Triple-Negative Breast Cancer (TNBC). Non-small-cell-lung-cancer (NSCLC). Head and neck squamous cell carcinoma (HNSCC). ABBV- ...https://clinicaltrials.gov/ct2/show/NCT03893955
Search of: bavituximab - List Results - ClinicalTrials.gov
Negative Breast Cancer. *Breast Cancer. *Triple Negative Breast Neoplasms. *Triple-Negative Breast Neoplasm ... Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer. *Metastatic Breast ... Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer. *Human Epidermal Growth Factor 2 ... Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer. *Carcinoma Breast Stage IV ...https://www.clinicaltrials.gov/ct2/results?term=bavituximab
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors - Full Text View - ClinicalTrials.gov
Triple Negative Breast Neoplasms. Pancreatic Neoplasms. Neoplasms. Neoplasms by Site. Neoplasms by Histologic Type. Endocrine ... Neoplasms, Glandular and Epithelial. Kidney Neoplasms. Kidney Diseases. Breast Neoplasms. Breast Diseases. Skin Diseases. ... Triple-negative Breast Cancer Ovarian Cancer Colo-rectal Cancer Drug: ADCT-301 Phase 1 ... Urogenital Neoplasms. Endocrine System Diseases. Digestive System Neoplasms. Digestive System Diseases. Urologic Neoplasms. ...https://www.clinicaltrials.gov/ct2/show/NCT03621982?term=NCT03621982&rank=1
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus...
... in neoadjuvant treatment of triple negative or HER2 positive breast cancer. Elig ... Triple Negative Breast Neoplasms / drug therapy*, mortality, pathology. Chemical. Reg. No./Substance: 0/Taxoids; 15H5577CQD/ ... in neoadjuvant treatment of triple negative or HER2 positive breast cancer. Eligible breast cancer patients were randomized to ... results from the NATT trial in triple negative or HER2 positive breast cancer. ...http://www.biomedsearch.com/nih/Acknowledgement-reviewers-2013/24292815.html
A Blood was drawn using the submandibular collection me | Open-i
... especially in triple-negative breast cancers (TNBCs). Furthermore, high ADAM8 levels predicted poor patient outcome. ... Neoplasm Metastasis. *Neoplastic Cells, Circulating/drug effects/metabolism/pathology. *Neovascularization, Pathologic/ ... especially in triple-negative breast cancers (TNBCs). Furthermore, high ADAM8 levels predicted poor patient outcome. ... ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. Romagnoli M, Mineva ND, Polmear M, ...https://openi.nlm.nih.gov/detailedresult.php?img=PMC3927960_emmm0006-0278-f6&req=4
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2...
Triple Negative Breast Neoplasms. Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not ... Breast Neoplasms, Male. Any neoplasms of the male breast. These occur infrequently in males in developed countries, the ... Neoplasms, usually carcinoma, located within the center of an organ or within small lobes, and in the case of the breast, ... and in the treatment of breast neoplasms in women.. ... LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor ...https://www.bioportfolio.com/resources/trial/129319/Lux-Breast-3-Afatinib-Alone-or-in-Combination-With-Vinorelbine-in-Patients.html
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple...
... of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast ... Clinical trial for Triple Negative Breast Neoplasms , A Study ... Patients With Early Relapsing Recurrent Triple-Negative Breast ... plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative breast cancer ( ...https://www.centerwatch.com/clinical-trials/listings/206723/triple-negative-breast-neoplasms-study-efficacy-safety-atezolizumab/?geo_lat=-29.8316729&geo_lng=30.9302603&radius=10
Triple Negative Breast Neoplasms (1). Vascular Endothelial Growth Factor A (1). ... View MoreDate Issued2013 (1)Has File(s)Yes ... Expression of VEGF and semaphorin genes define subgroups of triple negative breast cancer. Bender, R. Joseph; Mac Gabhann, ... Triple negative breast cancers (TNBC) are difficult to treat due to a lack of targets and heterogeneity. Inhibition of ... angiogenesis is a promising therapeutic strategy, but has had limited effectiveness so far in breast ... ...https://jscholarship.library.jhu.edu/handle/1774.2/36430/discover?filtertype_0=subject&filtertype_1=subject&filtertype_2=author&filter_relational_operator_1=equals&filtertype_3=subject&filter_relational_operator_0=equals&filter_2=Mac+Gabhann%2C+Feilim&filter_relational_operator_3=equals&filter_1=Triple+Negative+Breast+Neoplasms&filter_relational_operator_2=equals&filter_0=Vascular+Endothelial+Growth+Factor+A&filter_3=Neoplastic&filtertype=subject&filter_relational_operator=equals&filter=Semaphorins
iNOS knockdown impairs tumorigenicity and EMT by a dual | Open-i
Triple Negative Breast Neoplasms/drug therapy/genetics/metabolism*/mortality/pathology. Minor. *Activating Transcription Factor ... Introduction: Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with no effective targeted therapy. ... Introduction: Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with no effective targeted therapy. ... Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. ...https://openi.nlm.nih.gov/detailedresult.php?img=PMC4384389_13058_2015_527_Fig3_HTML&req=4
High Throughput Analysis Lab (HTAL)<...
Harnessing Druggable Synthetic Lethal Interactions in Triple-Negative Breast Cancer with Elevated MYC Expression. Clutter, M., ...https://www.scholars.northwestern.edu/en/organisations/high-throughput-analysis-lab-htal
Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer. Kalscheuer, S., Khanna, V., Kim, H., Li ... Breast Neoplasms Medicine & Life Sciences Somatomedins Medicine & Life Sciences Maltose-Binding Proteins Medicine & Life ... SWIFT MRI enhances detection of breast cancer metastasis to the lung. Kobayashi, N., Idiyatullin, D. S., Corum, C. A., Weber, J ... Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic ...https://experts.umn.edu/en/persons/deepali-sachdev
Patricia McLaughlin, MS, DEd - Research Output - Penn State
Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer. Zagon, I., ...https://pennstate.pure.elsevier.com/en/persons/patricia-mclaughlin/publications/?type=%2Fdk%2Fatira%2Fpure%2Fresearchoutput%2Fresearchoutputtypes%2Fcontributiontojournal%2Farticle
Phototheranostics of CD44-positive cell populations in triple negative breast cancer. Jin, J., Krishnamachary, B., Mironchik, Y ... Neoplasms Medicine & Life Sciences Precision Medicine Medicine & Life Sciences Nanoparticles Chemical Compounds ...https://jhu.pure.elsevier.com/en/persons/jiefu-jin
Platanias, L. C.<...
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer ... Cell-free DNA and circulating tumor cells: Comprehensive liquid biopsy analysis in advanced breast cancer. Rossi, G., Mu, Z., ... Optimizing Quality of Life in Women Living with Metastatic Breast Cancer: Feasibility and Preliminary Efficacy of a Tailored, ...https://www.scholars.northwestern.edu/en/persons/leonidas-c-platanias
Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer...
We investigated the role of COX-2 expressed by triple negative breast cancer cells in altering the structure and function of ... We investigated the role of COX-2 expressed by triple negative breast cancer cells in altering the structure and function of ... We investigated the role of COX-2 expressed by triple negative breast cancer cells in altering the structure and function of ... We investigated the role of COX-2 expressed by triple negative breast cancer cells in altering the structure and function of ...https://jhu.pure.elsevier.com/en/publications/breast-cancer-cell-cyclooxygenase-2-expression-alters-extracellul
Find Research Projects - University of North Carolina at Chapel Hill
Triple Negative Breast Neoplasms Breast Neoplasms Therapeutics Phosphotransferases Drug Therapy Cell-type and circuit-specific ... p16INK4a Gene Expression, Chemotherapy Toxicity, and Age in Women with Breast Cancer. Sharpless, N. E. & Muss, H. B. ... Hippo pathway activation in chemo-sensitive and -insensitive breast cancer. Johnson, G. L. ... Bariatric Surgery versus Dietary Interventions for Preventing Obesity-Related Breast Cancer: Roles of Epigenetic and Metabolic ...https://uncch.pure.elsevier.com/en/projects/?format=&page=6
Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions
Tomosynthesis is an innovative technique developed in digital mammography for obtaining a sectional image of the breast. Ma... ... Triple Negative Breast Neoplasms. Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not ... Breast Neoplasms, Male. Any neoplasms of the male breast. These occur infrequently in males in developed countries, the ... Breast Cancer Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to ...https://www.bioportfolio.com/resources/trial/169580/Evaluation-of-Tomosynthesis-for-Characterization-and-the-Management-of-Breast-Lesions.html
Erik Nelson - Research Output - University of Illinois at Urbana-Champaign
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin ... Neoplasm Metastasis Host CYP27A1 expression is essential for ovarian cancer progression. He, S., Ma, L., Baek, A. E., Vardanyan ... The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer. Mcdonnell, D. P., Chang, C. Y ... CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. Racioppi, L., Nelson, E ...https://experts.illinois.edu/en/persons/erik-nelson/publications/?type=%2Fdk%2Fatira%2Fpure%2Fresearchoutput%2Fresearchoutputtypes%2Fcontributiontojournal%2Farticle&ordering=publicationYearThenTitle&descending=false
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. ABCTB Investigators, GEMO ... Male Breast Neoplasms Medicine & Life Sciences Estrogen Receptors Medicine & Life Sciences Neoplasms Medicine & Life Sciences ... Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. NBCS Collaborators, ABCTB Investigators & ... Genome-wide association study of germline variants and breast cancer-specific mortality. NBCS Collaborators, Mar 19 2019, In : ...https://moh-it.pure.elsevier.com/en/persons/bernardo-bonanni
Find Research Projects - Creighton University
Triple Negative Breast Neoplasms Breast Neoplasms TNF-Related Apoptosis-Inducing Ligand Receptors ... Androgen Receptor: A Key Regulator of TRAIL Resistance in Breast Cancer?. Tu, Y. ...https://creighton.pure.elsevier.com/en/projects/
Triple Negative Breast Neoplasms Breast Neoplasms Micropatterning hippocampal neuronal networks for live cell imaging of ...https://pureportal.strath.ac.uk/en/persons/mairi-sandison
Gabriella Sozzi - Research Output - Italian Ministry of Health
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer. Forte, L., Turdo, F., Ghirelli, C., ... and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms. Milione, M. ... CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers. Turdo, F., Bianchi, F., Gasparini, P., ...https://moh-it.pure.elsevier.com/en/persons/gabriella-sozzi/publications/?type=%2Fdk%2Fatira%2Fpure%2Fresearchoutput%2Fresearchoutputtypes%2Fcontributiontojournal%2Farticle